These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30741041)

  • 1. Research on medication use in the neonatal intensive care unit.
    Allegaert K; Simons S; Van Den Anker J
    Expert Rev Clin Pharmacol; 2019 Apr; 12(4):343-353. PubMed ID: 30741041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Off-label and unlicensed drug use in Ayder comprehensive specialized hospital neonatal intensive care unit.
    Gidey MT; Gebretsadkan YG; Tsadik AG; Welie AG; Assefa BT
    Ital J Pediatr; 2020 Apr; 46(1):41. PubMed ID: 32245504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Off-label and unlicensed use of medicinal products in the neonatal setting in the Slovak Republic.
    Schweigertova J; Durisova A; Dolnikova D; Ondriasova E; Balazova M; Slezakova V; Kuzelova M
    Pediatr Int; 2016 Feb; 58(2):126-31. PubMed ID: 26256925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonates and medicines: a roadmap to further improve neonatal pharmaceutical care.
    Allegaert K; Sherwin C
    Eur J Pediatr; 2016 Jun; 175(6):743-6. PubMed ID: 26744132
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of off-label and unlicensed drugs in the neonatal intensive care unit and its association with severity scores.
    Carvalho CG; Ribeiro MR; Bonilha MM; Fernandes M; Procianoy RS; Silveira RC
    J Pediatr (Rio J); 2012; 88(6):465-70. PubMed ID: 23108602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Off-label and unlicensed drug use among neonatal intensive care units in Southern Italy.
    Laforgia N; Nuccio MM; Schettini F; Dell'Aera M; Gasbarro AR; Dell'Erba A; Solarino B
    Pediatr Int; 2014 Feb; 56(1):57-9. PubMed ID: 23937449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategy to address innovative off-label medication use in China: grading management.
    Wu H; Wu G
    Eur J Clin Pharmacol; 2014 Oct; 70(10):1271-3. PubMed ID: 25128075
    [No Abstract]   [Full Text] [Related]  

  • 8. Medication use in the neonatal intensive care unit: current patterns and off-label use of parenteral medications.
    Kumar P; Walker JK; Hurt KM; Bennett KM; Grosshans N; Fotis MA
    J Pediatr; 2008 Mar; 152(3):412-5. PubMed ID: 18280851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study.
    Pratico AD; Longo L; Mansueto S; Gozzo L; Barberi I; Tiralongo V; Salvo V; Falsaperla R; Vitaliti G; La Rosa M; Leonardi S; Rotondo A; Avola N; Sgarlata D; Damiano A; Tirantello M; Anzelmo G; Cipolla D; Rizzo A; Russo A; Ruggieri M; Salomone S; Drago F
    Curr Drug Saf; 2018; 13(3):200-207. PubMed ID: 29921210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence and pattern of pharmaceutical and excipient exposure in a neonatal unit in Slovenia.
    Fister P; Urh S; Karner A; Krzan M; Paro-Panjan D
    J Matern Fetal Neonatal Med; 2015; 28(17):2053-61. PubMed ID: 25316561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-sectional study of drug utilisation in a Chinese neonatal unit.
    Yue Y; Chen L; Choonara I; Xiong T; Ojha S; Tang J; Wang Y; Zeng L; Shi J; Wang H; Mu D
    J Int Med Res; 2020 May; 48(5):300060520914197. PubMed ID: 32468875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Off-label use and harmful potential of drugs in a NICU in Brazil: A descriptive study.
    de Souza AS; Dos Santos DB; Rey LC; Medeiros MG; Vieira MG; Coelho HLL
    BMC Pediatr; 2016 Jan; 16():13. PubMed ID: 26795213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quality improvement approach to optimizing medication use in the neonatal intensive care unit.
    Ellsbury DL; Ursprung R
    Clin Perinatol; 2012 Mar; 39(1):1-10. PubMed ID: 22341532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Off-label prescribing.
    Seale JP
    Med J Aust; 2014 Feb; 200(2):65. PubMed ID: 24484085
    [No Abstract]   [Full Text] [Related]  

  • 15. USE OF OFF-LABEL MEDICATIONS IN A NEONATAL INTENSIVE CARE UNIT.
    Koszma EIA; Bispo AJB; Santana IAO; Santos CNODBD
    Rev Paul Pediatr; 2021; 39():e2020063. PubMed ID: 33440406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of professional-led guideline workshops on clinical practice for the management of patent ductus arteriosus in preterm neonates in Japan: a controlled before-and-after study.
    Isayama T; Ye XY; Tokumasu H; Chiba H; Mitsuhashi H; Shahrook S; Kusuda S; Fujimura M; Toyoshima K; Mori R;
    Implement Sci; 2015 May; 10():67. PubMed ID: 25952042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The conundrum of off-label and unlicensed drug usage in neonatology.
    Jain L
    J Pediatr (Rio J); 2012; 88(6):449-51. PubMed ID: 23269115
    [No Abstract]   [Full Text] [Related]  

  • 18. Medicines prescription patterns in European neonatal units.
    Mesek I; Nellis G; Lass J; Metsvaht T; Varendi H; Visk H; Turner MA; Nunn AJ; Duncan J; Lutsar I
    Int J Clin Pharm; 2019 Dec; 41(6):1578-1591. PubMed ID: 31625122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacology in neonates: small size, huge variability.
    Allegaert K; van den Anker JN
    Neonatology; 2014; 105(4):344-9. PubMed ID: 24931327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug utilisation profile in the neonatal unit of a university hospital: a prospective observational study in Brazil.
    Gonçalves AC; Reis AM; Gusmão AC; Bouzada MC
    Int J Clin Pharm; 2015 Aug; 37(4):645-55. PubMed ID: 25832676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.